Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Displaying 3926 questions Show Answers
To ask the Scottish Government whether it will consider commissioning an independent review of whether the funding that is awarded by the Chief Scientist Office and the Scottish Funding Council for mental and physical health research is allocated on an equitable basis between both fields to help ensure that the highest quality work is carried out.
To ask the Scottish Government how much has been spent on (a) drugs and (b) other treatments for blood cancer in each year since 2015.
To ask the Scottish Government whether it considers that mental health research should be treated with the same status as that for physical health and, if so, how it will ensure that the funding allocated by the Chief Scientist Office and the Scottish Funding Council for such research reflects this.
To ask the Scottish Government what criteria it will use to select an impartial chair of the committee that will review mental health and incapacity legislation.
To ask the Scottish Government what plans it has to introduce and implement a national obesity strategy for adults and children, and what discussions (a) ministers and (b) its officials have had on the issue since January 2014.
To ask the Scottish Government whether it will publish data showing how many obese people there have been in (a) Scotland and (b) each NHS board area in each of the last five calendar years, broken down by (i) age and (ii) gender.
To ask the Scottish Government what steps it is taking to reduce disparities in levels of (a) adult and (b) childhood obesity on the basis of deprivation.
To ask the Scottish Government whether it will provide an update regarding how many sanitary products have been delivered to (a) hospitals, (b) schools, (c) colleges and (d) universities to be distributed for free.
To ask the Scottish Government what framework will be used following the interim funding period to assess medicines subject to the new ultra-orphan pathway.
To ask the Scottish Government when it will publish details of the process for agreeing commercial and data collection arrangements for medicines subject to the new ultra-orphan pathway.